Mark Dybul - Jul 19, 2021 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
Chief Executive Officer, Director
Signature
/s/ Mark R. Dybul
Stock symbol
RENB
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
4
Date filed
7/22/2021, 04:33 PM
Next filing
Sep 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Option to purchase shares of common stock Award $0 +2M $0.00 2M Jul 19, 2021 Common stock 2M $4.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest ratably on July 1, 2022, July 1, 2023 and July 1, 2024.